We first examined the impact of oophorectomy on BMD. 10 weeks after oophorectomy, mice were examined by microCT and BMD calculated from the femur. As expected, there was a significant decrease in BMD following oophorectomy compared to sham. Analysis of skeletal progenitors from uninjured bone showed significantly fewer mSSCs with decreased CFUs in oophorectomized versus sham. Following fracture, there was visibly less callus formed at the fracture site. Following fracture in oophorectomized mice, there was some increase in BCSPs in response, but it was nearly an order of magnitude less than seen in sham.
PURPOSE: Using a state of the art High Definition video animation we present our technique for orbital decompressions for patients with severe thyroid orbitopathy that minimizes complications while maximizing the amount of decompression. This method involves advancing the lateral orbital wall combined with endoscopic medial wall decompression in such a way as to promote osseous union and minimize cosmetic deformities. Stereotactic intraoperative navigation is utilized in all patients to minimize complications.
METHODS:
This paper represents a case series of over 150 orbits where orbital decompression for severe thyroid related orbitopathy was performed in a graded balanced manner. All patients were treated via a graded balanced orbital decompression with advancement of the lateral orbital wall with interpositional bone grafts. Preoperative and postoperative measurements were tabulated and statistically analyzed.
RESULTS:
All patients demonstrated significant improvement in proptosis with an average Hertel exophthalmometry reduction of 9 mm. The reduction in Hertel readings varied based on preoperative measurements and postoperative goals thereby demonstrating the "graded balanced" nature of our decompression technique. In addition, all patients with preoperative elevation of intraocular pressure demonstrated a reduction to within the normal range. Less than 5 percent of patients required post orbital decompression strabismus surgery. Of all patients, more than 70% demonstrated improvement of visual acuity of greater than 1 line. Postoperative computed tomography scan demonstrated osseous union of the lateral wall after advancement with this new technique.
CONCLUSION:
The graded balanced orbital decompression with interpositional bone grafts effectively decompressed the orbit with significant improvement in final visual acuity, exophthalmometry measurements, and final intraocular pressure. In addition, this technique promotes osseous union with minimal cosmetic deformities. This is one of the largest series of a graded balanced orbital decompression with intraoperative navigation and combined orbital and endoscopic orbital decompression. Our customized video animation effectively demonstrates our technique to patients for educational purposes. PURPOSE: IRF6 transcription factor is one of the most important genetic regulators of palate development, mutations of which result in cleft lip and palate (CLP). IRF6 directly regulates another transcription factor GRHL3 which is also a key regulator of palatogenesis and implicated in CLP pathogenesis. Therefore we hypothesized that systematic identification of IRF6 target genes will further elucidate the molecular regulation of palate development, and discover additional genetic determinants of CLP pathogenesis.
METHODS:
A irf6 zebrafish mutant was generated and used in a subtractive ChIP-seq and RNA-seq strategy. These datasets were overlapped to show genes directly under IRF6 transcriptional regulation and also differentially expressed between wild type and irf6 mutants. Integration of ChIPseq and mRNA-seq dataset enriched for a subset of irf6 target candidate genes of interest. We further refined this candidate gene list based on high-throughput gene expression studies and quantitative PCR of the relative expression levels of these genes in irf6-/-tissues compared to wild type controls.
RESULTS:
Several irf6 target genes were identified, shown to be down-regulated in irf6 mutants, and were previously not recognized to be regulated by Irf6. For example, epithelial splicing regulatory protein 1 (esrp1), is a RNA-binding protein that regulates alternative splicing in epithelial cells and has been shown to have a role in the alternative splicing of Fibroblast Growth Factor Receptors (FGFR), epithelial-to-mesenchymal transition and cell polarity. Esrp1 -/-mouse models have the presence of an anterior-to-poster fully penetrant cleft palate and microcephaly. Interestingly, irf6 -/-mutant mice also have cleft palate. Esrp1 knockout mice also have shortened limbs, suggesting a functional role for the protein in FGFR-regulated limb induction due to its role in FGFR alternative splicing. Furthermore, in irf6 -/-tissues, esrp1 expression levels were significantly reduced compared to wild type tissues.
CONCLUSIONS:
This work revealed esrp1 to be a direct downstream target of irf6. The craniofacial phenotype in an esrp1-/-mouse model suggests that esrp1 may be necessary for palate morphogenesis, acting under Irf6 regulation. Due to its function as a RNA-binding protein and role in FGFR slicing, studying the process by which esrp1 modulates craniofacial development and neural crest cell migration is ongoing. Current work also focuses on examining whole genome sequencing data from CLP trios to uncover ESRP1 gene variants to examine its role in cleft pathogenesis.
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